Sign inJoin waitlistJoin the waitlist

LS

Linda Stork

Pediatrics / Pediatric Hematology-Oncology · University Professional Services

Credentials: · · · ·

History

Denver Health Medical Center
1983–1986
Denver Health Medical Center
1979–1982
Columbia Univ Coll of Phys & Surgeons
1975–1979
Yale University
1970–1974

Research

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute…
Blood · 2002 · Last of 19 authors · 380 citations
Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331
Journal of Clinical Oncology · 2020 · 157 citations
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
Blood · 2011 · 111 citations

PG
Paul Gaynon
11 papers
Stephen Hunger
11 papers
BB
Bruce Bostrom
9 papers
NK
Nina Kadan-Lottick
9 papers · 2 as a fellow
Naomi Winick
7 papers
William Carroll
7 papers
YM
Yousif Matloub
7 papers
Joseph Neglia
6 papers
BC
Bill Chang
5 papers
GR
Gregory Reaman
5 papers
SL
Susan Lindemulder
5 papers
EB
Emmett Broxson
4 papers

Clinical trials

Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors
Study chair · Completed · Phase 1
Children's Oncology Group
2003–2008
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Study chair · Completed · Phase 3
Children's Oncology Group
1996–2007
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Site PI · Recruiting · Phase 3
Children's Oncology Group
2023–2029
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Site PI · Recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)
2022–2027